risperidone has been researched along with Hip Fractures in 4 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Hip Fractures: Fractures of the FEMUR HEAD; the FEMUR NECK; (FEMORAL NECK FRACTURES); the trochanters; or the inter- or subtrochanteric region. Excludes fractures of the acetabulum and fractures of the femoral shaft below the subtrochanteric region (FEMORAL FRACTURES).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Risperidone users were on average older (mean age of 68, 44, and 63 years for risperidone, other atypical antipsychotics, and typical antipsychotics respectively)." | 1.56 | Exposure to risperidone versus other antipsychotics and risk of osteoporosis-related fractures: a population-based study. ( Bahmanyar, S; Bodén, R; Clapham, E; Kieler, H; Qiu, H; Ramcharran, D; Reutfors, J; Svensson, T, 2020) |
| "To assess whether a "drugome-wide" screen with case-crossover design is a feasible approach for identifying candidate drugs and drug-drug interactions." | 1.46 | Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease. ( Hartikainen, S; Koponen, M; Lavikainen, P; Paananen, J; Taipale, H; Tanskanen, A; Tiihonen, J; Tolppanen, AM, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, SP | 1 |
| Liu, Y | 1 |
| Qiu, H | 2 |
| Tsai, KY | 1 |
| Wu, HC | 1 |
| Liang, WM | 1 |
| Shu, M | 1 |
| Chou, FH | 1 |
| Clapham, E | 1 |
| Bodén, R | 1 |
| Reutfors, J | 1 |
| Svensson, T | 1 |
| Ramcharran, D | 1 |
| Kieler, H | 1 |
| Bahmanyar, S | 1 |
| Tolppanen, AM | 2 |
| Taipale, H | 2 |
| Koponen, M | 2 |
| Tanskanen, A | 2 |
| Lavikainen, P | 2 |
| Paananen, J | 1 |
| Tiihonen, J | 2 |
| Hartikainen, S | 2 |
| Ahonen, R | 1 |
4 other studies available for risperidone and Hip Fractures
| Article | Year |
|---|---|
The risk of bone fracture after long-term risperidone exposure is not increased compared to other atypical antipsychotics: A retrospective cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Case-Control Studies; Female; Femo | 2019 |
Exposure to risperidone versus other antipsychotics and risk of osteoporosis-related fractures: a population-based study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Female; Fractures, Closed; Hip Fra | 2020 |
Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Codeine; Cross-Over Studies; Drug | 2017 |
Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Cohort Studies; Cross-Sectional St | 2017 |